Cargando…

Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis

BACKGROUND: The sustainability and generalizability of China’s dynamic zero-COVID strategy on eliminating SARS-CoV-2 transmission has casted doubt globally, mainly because it has exacted high social and economic cost. This study aimed to estimate the disease burden during the first wave of Omicron i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chongqing, Luo, Xia, Zhou, Zhen, Zeng, Xiaohui, Wan, Xiaomin, Yi, Lidan, Liu, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085878/
https://www.ncbi.nlm.nih.gov/pubmed/37062164
http://dx.doi.org/10.1016/j.jiph.2023.04.005
_version_ 1785022022256951296
author Tan, Chongqing
Luo, Xia
Zhou, Zhen
Zeng, Xiaohui
Wan, Xiaomin
Yi, Lidan
Liu, Qiao
author_facet Tan, Chongqing
Luo, Xia
Zhou, Zhen
Zeng, Xiaohui
Wan, Xiaomin
Yi, Lidan
Liu, Qiao
author_sort Tan, Chongqing
collection PubMed
description BACKGROUND: The sustainability and generalizability of China’s dynamic zero-COVID strategy on eliminating SARS-CoV-2 transmission has casted doubt globally, mainly because it has exacted high social and economic cost. This study aimed to estimate the disease burden during the first wave of Omicron in China and compared the cost-effectiveness of implementing a Real-world strategy (adjusted dynamic zero-COVID strategy) with two simulated strategies (routine and stricter dynamic zero-COVID strategy) to inform appropriate strategies for COVID-19 pandemic control. METHODS: A dynamic state-transition simulation model was developed to compare the health and cost outcomes between different dynamic zero-COVID strategies. Omicron-related healthcare costs were estimated from the societal perspective. Epidemiological parameter values were derived from data of real-world or generated by model calibration; costs and effectiveness parameter values were informed either by local data or published literature. The primary outcomes were total social cost, disability adjusted life-years (DALYs) and net monetary benefit (NMB). Deterministic sensitivity analyses (DSA) and scenario analyses were performed to assess the model robustness. RESULTS: The first wave of Omicron in Shanghai resulted in 47,646 DALYs lost and 415 billion RMB losses. At a willingness-to-pay threshold of 173,630 RMB (the GDP per capita of Shanghai in 2021) per DALY saved, the Real-world strategy was considered as the most cost-effective strategy due to its highest NMB (−407 billion). Results from DSA confirmed the robustness of our findings. CONCLUSION: Our finding supported the Real-world strategy taken by the Shanghai Municipal Government between March 1 and May 21, 2022 to control the first wave of Omicron outbreak. Moreover, our results indicated that whether the Stricter dynamic zero-COVID strategy is worth implementing at the beginning of the COVID-19 outbreak mainly depended on the infection rate of COVID-19 among primary contacts. Our analysis provides important evidence to inform policy makers to make appropriate decisions regarding COVID-19 pandemic management.
format Online
Article
Text
id pubmed-10085878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
record_format MEDLINE/PubMed
spelling pubmed-100858782023-04-11 Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis Tan, Chongqing Luo, Xia Zhou, Zhen Zeng, Xiaohui Wan, Xiaomin Yi, Lidan Liu, Qiao J Infect Public Health Original Article BACKGROUND: The sustainability and generalizability of China’s dynamic zero-COVID strategy on eliminating SARS-CoV-2 transmission has casted doubt globally, mainly because it has exacted high social and economic cost. This study aimed to estimate the disease burden during the first wave of Omicron in China and compared the cost-effectiveness of implementing a Real-world strategy (adjusted dynamic zero-COVID strategy) with two simulated strategies (routine and stricter dynamic zero-COVID strategy) to inform appropriate strategies for COVID-19 pandemic control. METHODS: A dynamic state-transition simulation model was developed to compare the health and cost outcomes between different dynamic zero-COVID strategies. Omicron-related healthcare costs were estimated from the societal perspective. Epidemiological parameter values were derived from data of real-world or generated by model calibration; costs and effectiveness parameter values were informed either by local data or published literature. The primary outcomes were total social cost, disability adjusted life-years (DALYs) and net monetary benefit (NMB). Deterministic sensitivity analyses (DSA) and scenario analyses were performed to assess the model robustness. RESULTS: The first wave of Omicron in Shanghai resulted in 47,646 DALYs lost and 415 billion RMB losses. At a willingness-to-pay threshold of 173,630 RMB (the GDP per capita of Shanghai in 2021) per DALY saved, the Real-world strategy was considered as the most cost-effective strategy due to its highest NMB (−407 billion). Results from DSA confirmed the robustness of our findings. CONCLUSION: Our finding supported the Real-world strategy taken by the Shanghai Municipal Government between March 1 and May 21, 2022 to control the first wave of Omicron outbreak. Moreover, our results indicated that whether the Stricter dynamic zero-COVID strategy is worth implementing at the beginning of the COVID-19 outbreak mainly depended on the infection rate of COVID-19 among primary contacts. Our analysis provides important evidence to inform policy makers to make appropriate decisions regarding COVID-19 pandemic management. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023-06 2023-04-11 /pmc/articles/PMC10085878/ /pubmed/37062164 http://dx.doi.org/10.1016/j.jiph.2023.04.005 Text en © 2023 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Tan, Chongqing
Luo, Xia
Zhou, Zhen
Zeng, Xiaohui
Wan, Xiaomin
Yi, Lidan
Liu, Qiao
Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title_full Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title_fullStr Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title_full_unstemmed Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title_short Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis
title_sort dynamic zero-covid strategy in controlling covid-19 in shanghai, china: a cost-effectiveness analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085878/
https://www.ncbi.nlm.nih.gov/pubmed/37062164
http://dx.doi.org/10.1016/j.jiph.2023.04.005
work_keys_str_mv AT tanchongqing dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT luoxia dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT zhouzhen dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT zengxiaohui dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT wanxiaomin dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT yilidan dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis
AT liuqiao dynamiczerocovidstrategyincontrollingcovid19inshanghaichinaacosteffectivenessanalysis